Vaccination

We want to have a conversation about human papillomavirus (HPV), starting with 6 questions about HPV people frequently ask our Cancer Research UK nurses.

Long awaited study results have confirmed that the quadrivalent human papillomavirus (HPV) vaccine substantially reduces invasive cervical cancer risk.  

Cervical cancer rates are predicted to fall following the introduction of HPV primary screening this year.

The Joint Committee for Vaccination and Immunisation has recommended that boys are offered the HPV vaccine. We look at what this could mean and next steps.

A vaccine to prevent cervical cancer is safe and effective in reducing cell changes, a new review has confirmed.

Following our research on how lifestyle affects cancer risk, we look at how research into vaccines, screening and drugs could also help prevent cancers.

Study finds that young adults in the US who hadn’t been vaccinated were around 14 times more likely to have oral HPV infections than those who were vaccinated.

In the second part of our World Cancer Day series, we take a look at cervical cancer rates in different parts of the world. Read on to find out what can be done to prevent the disease in the future.

Find out the details of the nine ideas that could answer one of our Grand Challenges in cancer prevention, diagnosis and treatment.

Around two-thirds of professionals who work in sexual health think the human papillomavirus (HPV) jab should be given to men who have sex with men